Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

No Thumbnail Available

Date

2004-06

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier Science

Abstract

Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.

Description

Keywords

Immunology, Surgery, Transplantation, Kidney-transplantation, Allograft recipients, Patient survival, Randomized-trial, Risk-factors, Mellitus, Immunosuppression, Cyclosporine, Insulin, FK506

Citation

Ersoy, A. vd. (2004). “Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus”. Transplantation Proceedings, 36(5), 1407-1410.